Literature DB >> 8302577

DNA synthesis-associated nuclear exclusion of p53 in normal human breast epithelial cells in culture.

K Takahashi1, K Suzuki.   

Abstract

Immunohistochemical staining using three monoclonal antibodies to p53 revealed that most normal human breast epithelial cells (HBEC) in the exponential growth phase, have p53 located in the nucleus but that some cells have the protein in the cytoplasm. Cytoplasmic staining of p53 with the monoclonal antibody PAb240 was inhibited by the specific oligopeptide, NTFRHSVVVP, that corresponds to the amino acids between 210 and 219 in p53 and which includes the epitope domain for PAb240. It was not inhibited by the control oligopeptide SPFVTVHNVR. Growth arrest of HBEC achieved by EGF depletion resulted in predominant nuclear location of p53 and stimulation of arrested cells with EGF induced transient nuclear exclusion of the protein when the induced DNA synthesis level was maximal. These observations suggest that p53 in normal HBEC becomes inactivated by nuclear exclusion during cellular DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8302577

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

Review 1.  Cell cycle checkpoints as therapeutic targets.

Authors:  Z A Stewart; J A Pietenpol
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

Review 2.  An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?

Authors:  Renu Wadhwa; Kazunari Taira; Sunil C Kaul
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

3.  Immunohistochemical analysis of p53 protein in transplant recipients with Kaposi's sarcoma.

Authors:  G Flamini; S Magalini; G Curigliano; G Nanni; A Boninsegna; S Agnes; D Faticato; M Castagneto; A Cittadini
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

4.  MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.

Authors:  O B Chernova; M V Chernov; Y Ishizaka; M L Agarwal; G R Stark
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

5.  p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.

Authors:  T Günther; R Schneider-Stock; J Rys; A Niezabitowski; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

6.  p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma.

Authors:  S Bosari; G Viale; M Roncalli; D Graziani; G Borsani; A K Lee; G Coggi
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

7.  Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma.

Authors:  R Soong; S Knowles; K E Williams; I G Hammond; S J Wysocki; B J Iacopetta
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.